-+ 0.00%
-+ 0.00%
-+ 0.00%

NEXENTIS ANNOUNCES MITOCAREX BIO ACHIEVES KEY R&D MILESTONE, GENERATING A SUBSTANTIALLY IMPROVED HIT MOLECULE ON THE PATH TO PRE-CLINICAL DEVELOPMENT

Reuters·05/18/2026 13:30:00

Please log in to view news